🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multi-center, dose-escalation and dose-expansion pha...
Status
Completed
Location
GenHarp Clinical Solutions
Start Date
2020-08-07
Trial ID
NCT04434482
Treatments Being Tested
This is a Phase I/Ib open-label, multicenter study to evaluate the safety, ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-03-29
Trial ID
NCT05262842
Treatments Being Tested
An open-label, randomized, single-dose, 2-way crossover study to compare th...
Status
Completed
Location
Syneos Health
Start Date
2020-10-29
Trial ID
NCT04351165
Treatments Being Tested
This is a Phase I, first-in-human, open-label, dose-escalation study of IMP...
Status
Completed
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2017-08-23
Trial ID
NCT03508011
Treatments Being Tested
An open-label, randomized, single-dose, two-way crossover bioequivalence st...
Status
Completed
Location
Xuzhou Central Hospital
Start Date
2022-06-08
Trial ID
NCT05390944
Treatments Being Tested
A phase I, single-site, open-label, randomized, single-dose, two-way crosso...
Status
Completed
Location
Shanghai Public Health Clinical Center
Start Date
2019-07-22
Trial ID
NCT04057729
Treatments Being Tested
A phase II, multi-center, open-label, single-arm, non-randomized study to e...
Status
Completed
Location
Xiaohua.Wu
Start Date
2019-10-28
Trial ID
NCT04089189
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Senapar...
Status
Unknown
Location
Our lady of Lourdes Urology
Start Date
2021-12-31
Trial ID
NCT04822961
A Phase I, Open-label, Fixed-Sequence Study to Evaluate the Effect of Multi...
Status
Completed
Location
Impact Therapeutics, Inc.
Start Date
2020-11-02
Trial ID
NCT04584515
Treatments Being Tested
This is a phase 1, First-In-Human, open label study, trialing a new PARP (p...
Status
Completed
Location
Blacktown Hospital
Start Date
2017-02-03
Trial ID
NCT03507543
Treatments Being Tested